Jennison Associates LLC Karuna Therapeutics, Inc. Call Options Transaction History
Jennison Associates LLC
- $149 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KRTX
# of Institutions
13Shares Held
333KCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V8213KShares$00.06% of portfolio
-
Tekla Capital Management LLC58.6KShares$00.5% of portfolio
-
International Biotechnology Trust PLC London, X030.5KShares$01.75% of portfolio
-
Ea Series Trust Havertown, PA12.8KShares$00.1% of portfolio
-
Brinker Capital Investments, LLC6.1KShares$00.02% of portfolio
About Karuna Therapeutics, Inc.
- Ticker KRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,965,000
- Description
- Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...